The lawsuit alleges that Calix misled shareholders regarding its financial health during the first quarter of 2026. Specifically, the complaint claims the company failed to disclose that its margins were artificially bolstered by an advanced supply of memory components that was rapidly depleting. As this stockpile dwindled, Calix was reportedly forced to acquire components at higher market prices, creating significant negative pressure on margins that had not been communicated to the market.
Calix Investors Face July Deadline in Securities Fraud Lawsuit
Investors who purchased Calix, Inc. securities between January 28 and April 21, 2026, face a July 27 deadline to petition the court to serve as lead plaintiff in a pending class action lawsuit, according to a notice issued by the Rosen Law Firm.
Investors seeking to participate in the litigation may do so through a contingency fee arrangement, which requires no out-of-pocket costs. While the class has not yet been certified, those who purchased stock during the designated period may choose to retain their own counsel or remain as absent class members. Interested parties can contact attorney Phillip Kim at the Rosen Law Firm for further information regarding the filing and the process for acting as a lead plaintiff.
Comments (0)
No comments yet. Be the first!